循环GMP-AMP合成酶在癌症预防中的作用
Weidong Chen1,2, Ga-Eun Lee1,2, Dohyun Jeung1,2
1BK21-Four, College of Pharmacy, The Catholic University of Korea.
Journal of cancer prevention
|January 11, 2024
概括
循环GMP-AMP合成酶 (cGAS) 检测细胞质DNA,通过cGAS-STING通路启动炎症反应. 通过调节cGAS活性,抑制这种途径提供了潜在的化学预防策略.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 循环GMP-AMP (cGAMP) 是一种由cGAMP合成酶 (cGAS) 合成的二次信使.
- 细胞质DNA的cGAS激活触发了cGAS-STING信号通路,诱导炎症和细胞因子的产生.
- 细胞质DNA可以来自受损的宿主DNA或微生物病原体.
研究的目的:
- 审查调节cGAS活性在治疗应用中的潜力.
- 讨论cGAMP作为二级信息传递者的作用.
- 通过cGAS探索自我与外来DNA歧视的机制及其核功能.
主要方法:
- 对cGAS-STING通路的文献综述.
- 对cGAMP合成和功能的分析.
- 在路径中讨论潜在的治疗目标.
主要成果:
- cGAS-STING通路是对细胞质DNA反应的先天免疫和炎症的关键调解者.
- 调节cGAS活性为开发化疗预防剂提供了一个有希望的途径.
- 了解cGAS的DNA传感机制和核作用对于有针对性的干预至关重要.
结论:
- 向cGAS-STING通路具有显著的治疗潜力,特别是在炎症性疾病和癌症化学预防方面.
- 对cGAS的确切功能和监管机制的进一步研究是有必要的.
- 对cGAS-STING通路的抑制剂可以提供新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K


